We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
This Fund
S&P 500
This Quarter
Est. Return
+5.45%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$180M
AUM Growth
+$35.3M
(+24%)
Cap. Flow
+$33.3M
Cap. Flow
% of AUM
18.49%
Top 10 Holdings %
Top 10 Hldgs %
21.58%
Holding
287
New
78
Increased
46
Reduced
73
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$4.54M |
| 2 |
Coherus Oncology
CHRS
|
+$3.29M |
| 3 |
Amylyx Pharmaceuticals
AMLX
|
+$2.71M |
| 4 |
Embecta
EMBC
|
+$2.55M |
| 5 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$4.1M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.81M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.81M |
| 4 |
Innoviva
INVA
|
+$2.07M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 59.9% |
| 2 | Real Estate | 10.66% |
| 3 | Financials | 4.01% |
| 4 | Technology | 3.46% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Norwegian Cruise Line
NCLH
$8.89B
| $129K | 0.07% |
+5,912
| New | +$90.5K |
|
177
iShares MSCI Netherlands ETF
EWN
$562M
| $128K | 0.07% |
2,959
-538
| -15% | -$22.8K |
|
178
iShares MSCI Austria ETF
EWO
$146M
| $128K | 0.07% |
6,305
-350
| -5% | -$7.16K |
|
179
iShares MSCI Sweden ETF
EWD
$522M
| $128K | 0.07% |
3,608
-47
| -1% | -$1.68K |
|
180
iShares MSCI Germany ETF
EWG
$1.5B
| $127K | 0.07% |
4,428
-800
| -15% | -$23K |
|
181
iShares MSCI United Kingdom ETF
EWU
$4.04B
| $126K | 0.07% |
3,884
-536
| -12% | -$17.7K |
|
182
Diamondback Energy
FANG
$57.6B
| $124K | 0.07% |
947
-1,797
| -65% | -$241K |
|
183
iShares MSCI Switzerland ETF
EWL
$2.12B
| $124K | 0.07% |
2,678
+15
| +0.6% | +$706 |
|
|
PXD
184
DELISTED
Pioneer Natural Resource Co.
PXD
| $122K | 0.07% |
588
-659
| -53% | -$139K |
|
185
BorgWarner
BWA
$13.2B
| $121K | 0.07% |
+2,817
| New | +$116K |
|
186
American International
AIG
$41.9B
| $120K | 0.07% |
2,092
-2,259
| -52% | -$121K |
|
187
Tapestry
TPR
$28.8B
| $119K | 0.07% |
+2,791
| New | +$116K |
|
188
Hartford Financial Services
HIG
$38.5B
| $119K | 0.07% |
1,647
-146
| -8% | -$10.3K |
|
189
Jabil
JBL
$32.8B
| $116K | 0.06% |
+1,073
| New | +$94.5K |
|
190
Royal Caribbean
RCL
$78.7B
| $115K | 0.06% |
+1,105
| New | +$86.6K |
|
191
Star Holdings Shares of Beneficial Interest
STHO
$112M
| $114K | 0.06% |
7,744
| – | – |
|
192
Coupang
CPNG
$27.8B
| $110K | 0.06% |
+6,336
| New | +$103K |
|
193
Principal Financial Group
PFG
$23.6B
| $110K | 0.06% |
1,448
-70
| -5% | -$5.05K |
|
194
Everest Group
EG
$15.2B
| $108K | 0.06% |
+317
| New | +$114K |
|
195
Apollo Global Management
APO
$70.7B
| $108K | 0.06% |
+1,406
| New | +$94K |
|
196
Archer Daniels Midland
ADM
$41.4B
| $107K | 0.06% |
1,420
-1,551
| -52% | -$117K |
|
197
Arch Capital
ACGL
$36.1B
| $106K | 0.06% |
+1,412
| New | +$102K |
|
198
Canadian Natural Resources
CNQ
$96.9B
| $103K | 0.06% |
3,668
-90
| -2% | -$2.57K |
|
199
Wynn Resorts
WYNN
$10.1B
| $103K | 0.06% |
+974
| New | +$104K |
|
200
Las Vegas Sands
LVS
$30.5B
| $99.8K | 0.06% |
+1,720
| New | +$102K |
|
Similar funds
AIS
IVGAI
OIM
TIP
RCG
CWM
SPW
WLC
AlphaCentric Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, AlphaCentric Advisors held 287 positions worth $180M, up 24% from $145M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $33.3M of net new capital in Q2 2023, opening 78 new positions and adding to 46 existing holdings. Its largest new stake was Embecta: 93,500 shares worth $2.02M.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $4.1M trimmed.
- AlphaCentric Advisors's largest Q2 2023 buy was Embecta: 93,500 shares worth $2.02M.
- AlphaCentric Advisors added most to Jazz Pharmaceuticals in Q2 2023, an estimated $4.54M increase.
- AlphaCentric Advisors's biggest Q2 2023 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $4.1M.
- AlphaCentric Advisors fully exited Invesco QQQ Trust in Q2 2023, selling an estimated $2.81M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $180M portfolio in Q2 2023.
- AlphaCentric Advisors opened 78 new positions and closed 55 in Q2 2023.
- AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $180M.
Based on AlphaCentric Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.